4-(2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)benzene-1,2-diol

Catalog No. :
ACSIKT627
CAS No. :
34368-04-2
Molecular Formula :
C18H23NO3
Molecular Weight :
301.39

IUPAC Name:4-(2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)benzene-1,2-diol

4-(2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)benzene-1,2-diol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)benzene-1,2-diol
IUPAC Name4-(2-((4-(4-hydroxyphenyl)butan-2-yl)amino)ethyl)benzene-1,2-diol
MDL No.MFCD00072085
Molecular FormulaC18H23NO3
Molecular Weight301.39
SMILESCC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1
InChI KeyJRWZLRBJNMZMFE-UHFFFAOYSA-N
Synonym[+/-]-3,4-DIHYDROXY-N-[3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-BETA-PHENETHYLAMINE HYDROCHLORIDE;4-[2-[4-(4-HYDROXYPHENYL)BUTAN-2-YLAMINO]ETHYL]BENZENE-1,2-DIOL;4-{2-[3-(4-Hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol;1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-;1,2-Benzenediol, 4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-, (+-)-;Compound 81929;DL-Dobutamine;Racemic dobutamine
CAS No.34368-04-2

Synthetic Route by SureRoute

1. ACSIKT627 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  4. Plus
  5. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  6. Then
  7. ACSIKT627 route product structure diagram
    ACSIKT62734368-04-2
Inquiry

2. ACSIKT627 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSIKT627 route product structure diagram
    ACSIKT62734368-04-2
Inquiry

Comments (0)